Losartan description: Difference between revisions

Jump to navigation Jump to search
No edit summary
(Redirected page to Losartan#Pharmacology)
 
Line 1: Line 1:
__NOTOC__
#REDIRECT [[Losartan#Pharmacology]]
{{Losartan}}
{{CMG}}; {{AE}} {{SS}}
 
==Description==
 
 
COZAAR (losartan potassium) is an angiotensin II receptor (type AT1) antagonist. Losartan potassium, a non-peptide molecule, is chemically described as 2-butyl-4-chloro-1-[p-(o-1H-tetrazol-5-ylphenyl)benzyl]imidazole-5-methanol monopotassium salt.
 
Its empirical formula is C22H22ClKN6O, and its structural formula is:
 
{|
|[[File:Losartan-3D-spacefill.png|thumb|800px]]
|}
 
{|
|[[File:Losartan01.jpg|thumb|800px]]
|}
Losartan potassium is a white to off-white free-flowing crystalline powder with a molecular weight of 461.01. It is freely soluble in water, soluble in alcohols, and slightly soluble in common organic solvents, such as acetonitrile and methyl ethyl ketone. Oxidation of the 5-hydroxymethyl group on the imidazole ring results in the active metabolite of losartan.
 
COZAAR is available as tablets for oral administration containing either 25 mg, 50 mg or 100 mg of losartan potassium and the following inactive ingredients: microcrystalline cellulose, lactose hydrous, pregelatinized starch, magnesium stearate, hydroxypropyl cellulose, hypromellose, and titanium dioxide.
 
COZAAR 25 mg, 50 mg and 100 mg tablets contain potassium in the following amounts: 2.12 mg (0.054 mEq), 4.24 mg (0.108 mEq) and 8.48 mg (0.216 mEq), respectively. COZAAR 25 mg, COZAAR 50 mg, and COZAAR 100 mg may also contain carnauba wax.<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = COZAAR (LOSARTAN POTASSIUM) TABLET, FILM COATED [MERCK SHARP & DOHME CORP.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5ac32c20-169d-475a-fc8a-934f758d6ab0 | publisher =  | date =  | accessdate = 20 February 2014 }}</ref>
 
 
==References==
 
{{Reflist}}
 
{{Angiotensin II receptor antagonists}}
 
[[Category:Alcohols]]
[[Category:Angiotensin II receptor antagonists]]
[[Category:Imidazoles]]
[[Category:Organochlorides]]
[[Category:Tetrazoles]]
[[Category:Biphenyls]]
[[Category:Cardiovascular Drugs]]
[[Category:Drugs]]

Latest revision as of 01:13, 22 July 2014